Association Between an Acute, Drug-Induced Decrease in High-Density Lipoprotein Cholesterol Levels and Risk of Cardiovascular Events
ConclusionPatients with a short-term, drug-induced decrease in HDL-C had a moderately increased long-term risk of CV events compared with those with constant HDL-C levels.Trial Registration Number207595 (GlaxoSmithKline Trial registry;https://www.gsk-studyregister.com/).
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Drugs & Pharmacology | Heart | Ischemic Stroke | Statin Therapy | Stroke | Study